Auxilius Pharma to advance angina drug with $4 million financing
Biotechnology company Auxilius Pharma has announced a $4 million Series A financing round to accelerate the development of a chronic stable angina treatment. AUX-001 has been designed by Auxilius as a once-daily formulation, designed to treat and prevent chronic stable angina. The candidate could become the first… Read More